WOLF.V Grey Wolf Animal Health Corp.

Healthcare Diversified Consumer Services TSX Venture Exchange
1.68 CAD
Close of Nov 7, 2026
1.20 1.85
Market cap
CAD 58.2M
P/E
33.6x
P/B
1.83x
ROE
4.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is WOLF.V undervalued?

Graham number
Price1.68
Graham value1.02
Premium65.5%

WOLF.V trades 65.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Grey Wolf Animal Health Corp. fundamental analysis

No fundamental analysis for Grey Wolf Animal Health Corp. yet.

Grey Wolf Animal Health Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Grey Wolf Animal Health Corp.

Grey Wolf Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedat…

Full company profile